JP4544895B2 - Method for producing dihydropyridine derivatives - Google Patents

Method for producing dihydropyridine derivatives Download PDF

Info

Publication number
JP4544895B2
JP4544895B2 JP2004108165A JP2004108165A JP4544895B2 JP 4544895 B2 JP4544895 B2 JP 4544895B2 JP 2004108165 A JP2004108165 A JP 2004108165A JP 2004108165 A JP2004108165 A JP 2004108165A JP 4544895 B2 JP4544895 B2 JP 4544895B2
Authority
JP
Japan
Prior art keywords
reaction
producing
group
formula
derivative according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004108165A
Other languages
Japanese (ja)
Other versions
JP2005289894A (en
Inventor
賢一 浪江
康弘 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dai Nippon Printing Co Ltd
Original Assignee
Dai Nippon Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dai Nippon Printing Co Ltd filed Critical Dai Nippon Printing Co Ltd
Priority to JP2004108165A priority Critical patent/JP4544895B2/en
Publication of JP2005289894A publication Critical patent/JP2005289894A/en
Application granted granted Critical
Publication of JP4544895B2 publication Critical patent/JP4544895B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

本発明は血管拡張剤、抗高血圧剤として優れた治療効果を有する活性成分である化合物、例えば、2,6−ジメチル−4−(3−ニトロフェニル)−1,4−ジヒドロピリジン−3,5−ジカルボン酸−3−(1−ベンジル−3−ピペリジル)エステル−5−メチルエステルの塩酸塩(塩酸ベニジピン)に代表されるジヒドロピリジン誘導体の新規な製造法に関するものである。 The present invention is a compound which is an active ingredient having an excellent therapeutic effect as a vasodilator and antihypertensive agent, for example, 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3,5- The present invention relates to a novel process for producing a dihydropyridine derivative represented by hydrochloride (benidipine hydrochloride) of dicarboxylic acid-3- (1-benzyl-3-piperidyl) ester-5-methyl ester.

多くの4−アリール−1,4−ジヒドロ−2,6−ジアルキル−3,5−ピリジンジカルボン酸非対称エステルは、これらの化合物が工業規模で生産され始めて以来、最終生成物の収率や純度を改善するための努力が活発に行なわれている。 Many 4-aryl-1,4-dihydro-2,6-dialkyl-3,5-pyridinedicarboxylic acid asymmetric esters have reduced the yield and purity of the final product since these compounds began to be produced on an industrial scale. There are active efforts to improve.

ジヒドロピリジン類の製造法としては、
A法:ジヒドロピリジンモノカルボン酸クロライドとアルコール類からの合成{Chem.Pharm.Bull,28,2809(1980)}に準じた方法
B法:ベンツアルデヒド類、3−アミノクロトン酸エステル類、アシル酢酸エステル類で一段階で合成する方法。所謂Hantzsch合成
C法:ベンツアルデヒド類、アシル酢酸エステル類とアンモニア(またはアンモニウム塩)との反応で一段階で合成する方法{J.Med.Chem,17,956,(1974)}に準じた方法
D法:ベンジリデンアシル酢酸エステルと3−アミノクロトン酸エステル類からの合成{Chem.Pharm.Bull,27,1426(1979)}に準じた方法
等が知られている。
As a production method of dihydropyridines,
Method A: Synthesis from dihydropyridine monocarboxylic acid chloride and alcohol Method B according to {Chem. Pharm. Bull, 28, 2809 (1980)} Method B: Benzaldehydes, 3-aminocrotonates, acyl acetates To synthesize in one step. So-called Hantzsch synthesis method C: a method of synthesizing in one step by reaction of benzaldehydes, acylacetates and ammonia (or ammonium salt) {J. Med. Chem. 17, 956, (1974)} Method D: Synthesis from benzylidene acyl acetate and 3-aminocrotonate {Chem. Pharm. Bull, 27, 1426 (1979)} Etc. are known.

しかしながら、これら従来の方法においては次の如き重大な欠点が存在している。
A法では、一旦2,6−ジアルキル−1,4−ジヒドロピリジンジカルボン酸
対称または非対称エステルを合成した後に、片方のエステルを選択的に加水分解し、酸クロライド化、再エステル化を行なわなければならず、工程数が長く且つ低収率となる。
B法およびC法は、一段階で合成できるため操作性は向上するが、好ましくない副生物が多量に生成し、その除去は困難を極め、これに多大な労力、費用を費やす結果となり、最終的に低収率でしか目的物を得られない。
However, these conventional methods have the following serious drawbacks.
In Method A, once 2,6-dialkyl-1,4-dihydropyridinedicarboxylic acid
After synthesizing a symmetric or asymmetric ester, one ester must be selectively hydrolyzed, acid chlorided and reesterified, resulting in a long number of steps and a low yield.
Method B and method C can be synthesized in one step, so that the operability is improved. However, a large amount of undesired by-products are produced, and it is extremely difficult to remove them. In particular, the target product can be obtained only in a low yield.

D法が工業的には一般的ではあるが、トルエンなどの水不混和性溶媒中で行なわれる時は副生物の生成は抑制されるが、反応速度が極端に遅くなる。逆にプロトン性溶媒中で環化反応が完了するまで還流すると、強酸を添加しない場合には望ましくない副生物が許容できないほど生成する。この副生物を目的生成物から除去することは必要不可欠であるが、この操作には複雑困難な操作とそれに伴う多大なコストを必要とする。
強酸添加の場合には副反応はある程度抑制されるが、反応容器や鋼製装置の使用制限の要因になり、操作上の危険性を増加させることになる。また、用いた酸を除くための処理にも、労力とコストが掛かる上、環境的負荷も無視できない。更には、副反応を抑制するために、原料となるベンジリデンアシル酢酸エステルも高純度のものを使用しなければならず、そのために掛かる労力と費用も多大なものになる。
以上の様に、従来の方法では工業生産上多くの欠点を抱えている。
Chem.Pharm.Bull,28,2809(1980) J.Med.Chem,17,956,(1974) Chem.Pharm.Bull,27,1426(1979)
Although the method D is industrially common, when it is carried out in a water-immiscible solvent such as toluene, by-product formation is suppressed, but the reaction rate becomes extremely slow. Conversely, refluxing in a protic solvent until the cyclization reaction is complete produces unacceptably undesired by-products without the addition of a strong acid. Although it is indispensable to remove this by-product from the target product, this operation requires a complicated operation and a great amount of cost.
In the case of addition of a strong acid, side reactions are suppressed to some extent, but it becomes a factor for restricting the use of the reaction vessel and the steel device, and increases the operational risk. In addition, the treatment for removing the acid used requires labor and cost, and the environmental load cannot be ignored. Furthermore, in order to suppress a side reaction, the benzylidene acyl acetate used as a raw material must also have a high purity, and the labor and cost required for that purpose are also great.
As described above, the conventional method has many drawbacks in industrial production.
Chem. Pharm. Bull, 28, 2809 (1980) J. et al. Med. Chem, 17, 956, (1974) Chem. Pharm. Bull, 27, 1426 (1979)

本発明は、ジヒドロピリジン誘導体の製造において、特にD法における種々の課題を解決し、非常に単純な作業で高収率で非常に純度の高いジヒドロピリジン誘導体を得られる工業製法を提供することにある。 An object of the present invention is to provide an industrial process capable of solving various problems particularly in the method D in the production of a dihydropyridine derivative and obtaining a highly pure dihydropyridine derivative in a high yield with a very simple operation.

本発明の方法は、
下記一般式(1)

Figure 0004544895
[式中R1は、水素原子、ニトロ基、シアノ基、ハロゲン基、トリフルオロメチル基を表す。式中R2は、C1―C6の直鎖、分岐或いは環状の置換又は無置換アルキル基を表す。式中R3は、アルキル基を表す]で表されるベンジリデンアセト酢酸エステル類と
下記一般式(2)

Figure 0004544895

[式中R4は、アルキル基を表す。式中R5は、R2と異なる直鎖、分岐或いは環状の炭素数12までのアルキル基で任意にN原子で置換されていてもよく、更にN原子はC1―C6置換又は無置換アルキル基或いは芳香環が置換されたベンジル基で置換されていてもよい。]で表されるアミノクロトン酸エステル類との反応において、有機溶媒中で反応系内に乾燥剤および/または脱水剤を添加し、副生する水を除去しながら反応を行なうことを特徴とする
下記一般式(3)
Figure 0004544895

[式中R1、R2、R3、R4、R5は前記と同一である]で表されるジヒドロピリジン誘導体の高効率で工業化に適した製造法を提供するものである。 The method of the present invention comprises:
The following general formula (1)
Figure 0004544895
[Wherein R 1 represents a hydrogen atom, a nitro group, a cyano group, a halogen group, or a trifluoromethyl group. In the formula, R2 represents a C1-C6 linear, branched or cyclic substituted or unsubstituted alkyl group. In the formula, R3 represents an alkyl group] and benzylideneacetoacetic acid esters represented by the following general formula (2)

Figure 0004544895

[Wherein R 4 represents an alkyl group. In the formula, R5 may be optionally substituted with a linear, branched or cyclic alkyl group having up to 12 carbon atoms different from R2, and the N atom may be a C1-C6 substituted or unsubstituted alkyl group or an aromatic group. The ring may be substituted with a substituted benzyl group. In the reaction with the aminocrotonic acid ester represented by the formula, the reaction is carried out while adding a desiccant and / or a dehydrating agent to the reaction system in an organic solvent and removing by-product water. The following general formula (3)
Figure 0004544895

[Wherein R1, R2, R3, R4, and R5 are the same as described above], and provides a highly efficient production method suitable for industrialization.

本発明によれば、非常に単純な、自由度の高い反応条件で副生物の生成がほとんど無い高純度のジヒドロピリジン誘導体の製造が可能となり、工業上の利用価値が極めて高い。
According to the present invention, it is possible to produce a high-purity dihydropyridine derivative having very simple and highly flexible reaction conditions with almost no by-product, and its industrial utility value is extremely high.

本発明の製造方法を詳細に説明する。
本発明で使用される一般式(1)は置換ベンズアルデヒド化合物とアセト酢酸エステルとの縮合反応により容易に入手することが出来る。例えば、m−ニトロベンツアルデヒドとアセト酢酸メチルを触媒量の塩基の存在下で有機溶媒中で攪拌することで容易に生成し、高収率で得ることが出来る。
The production method of the present invention will be described in detail.
The general formula (1) used in the present invention can be easily obtained by a condensation reaction between a substituted benzaldehyde compound and an acetoacetate ester. For example, m-nitrobenzaldehyde and methyl acetoacetate can be easily produced by stirring in an organic solvent in the presence of a catalytic amount of a base, and can be obtained in high yield.

本発明で使用される一般式(2)はジケテンと対応するアルコールでアセト酢酸エステルを合成し、更にアンモニアとの反応により容易に入手することが出来る。例えば、N−ベンジル−3−ヒドロキシピペリジンとジケテンとを溶媒中で反応させて取り出した後、溶媒中でアンモニアと反応、濃縮することにより高収率で得ることが出来る。 The general formula (2) used in the present invention can be easily obtained by synthesizing an acetoacetate ester with an alcohol corresponding to diketene and further reacting with ammonia. For example, it can be obtained in a high yield by reacting N-benzyl-3-hydroxypiperidine and diketene in a solvent and taking out, then reacting with ammonia in the solvent and concentrating.

これら化合物(1)と(2)を反応させて一般式(3)の最終生成物を得る工程は、メタノール、エタノール、プロパノール等の低級脂肪族アルコール、メチルセロソルブ、エチルセロソロブ、酢酸エチル、酢酸メチル、酢酸ブチル、ジオキサン、DMF、DMSO(ジメチルスルホキシド)、CCl4、CHCl3,CH2Cl2、THF、ヘキサン、リグロイン、メチルエチルケトン、メチルイソブチルケトン、アセトン、トルエン、ベンゼン、キシレン、アセトニトリル等の溶媒中、好ましくはアルコール系溶媒中、溶媒由来の副生物抑制の観点から特に好ましくはエタノールを反応溶媒として行なわれる。
反応から副生する水を除くために乾燥剤および/または脱水剤が使用されるが、主に無水硫酸マグネシウム、無水硫酸ナトリウム、ゼオライトなどが使用され、副生物抑制の観点から特に好ましくはモレキュラーシーブを添加して反応を行なう。
反応は、室温乃至加温下(好ましくは50℃−還流)で1時間乃至24時間(好ましくは5−10時間)攪拌しながら行なわれる。
The step of reacting these compounds (1) and (2) to obtain the final product of the general formula (3) includes lower aliphatic alcohols such as methanol, ethanol and propanol, methyl cellosolve, ethyl cellosorb, ethyl acetate, methyl acetate, Of solvents such as butyl acetate, dioxane, DMF, DMSO (dimethyl sulfoxide), CCl4, CHCl3, CH2Cl2, THF, hexane, ligroin, methyl ethyl ketone, methyl isobutyl ketone, acetone, toluene, benzene, xylene, acetonitrile, preferably alcohol solvents Among these, ethanol is particularly preferably used as a reaction solvent from the viewpoint of suppression of solvent-derived byproducts.
A desiccant and / or a dehydrating agent is used to remove water produced as a by-product from the reaction, and anhydrous magnesium sulfate, anhydrous sodium sulfate, zeolite, etc. are mainly used, and molecular sieves are particularly preferable from the viewpoint of suppression of by-products. Is added to carry out the reaction.
The reaction is carried out at room temperature to warming (preferably 50 ° C.-reflux) with stirring for 1 hour to 24 hours (preferably 5-10 hours).

このようにして得られた一般式(3)で示されるジヒドロピリジン誘導体は、反応液を一般的な濾過、抽出および/または濃縮、蒸留することによって単離される。所望により公知方法、例えばカラムクロマト、蒸留、再結晶等により精製することが可能である。 The dihydropyridine derivative represented by the general formula (3) thus obtained is isolated by subjecting the reaction solution to general filtration, extraction and / or concentration and distillation. If desired, it can be purified by known methods such as column chromatography, distillation, recrystallization and the like.

以下に、実施例を掲げて本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.

実施例1
2,6−ジメチル−4−(3−ニトロフェニル)−1,4−ジヒドロピリジン−3,5−ジカルボン酸−3−(1−ベンジル−3−ピペリジニル)エステル−5−メチルエステルの塩酸塩(塩酸ベニジピン)の合成
2−(3−ニトロベンジリデン)アセト酢酸メチルエステル25g(0.1mol)と3−アミノクロトン酸−3−(N−ベンジル)ピペリジニルエステル33g(0.11mol)とモレキュラーシーブ15g及びエタノールの溶液を50℃にて10時間反応した。次いで、モレキュラーシーブ除去後に溶媒を留去して得られた残留物にクロロホルム150ml、35%塩酸52gを加え室温で30分反応させ、目的の塩酸塩をつくる。次いで溶媒を留去して得られた残留物にエタノール/アセトン=65ml/130mlにて溶解し、攪拌しながらゆっくりと5℃以下まで冷却する。約20時間後、析出した結晶を濾取して、アセトンで洗浄し、次いでデシケーター中室温で減圧乾燥した。融点198℃の黄色の結晶、すなわち、塩酸ベニジピン19gを得た。収率70%。HPLCで分析した結果、主用成分の面積百分率は目的化合物99.9%、ジ3−(N−ベンジル)ピペリジニルエステルは0.1%であった。
Example 1
Hydrochloride of 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid-3- (1-benzyl-3- piperidinyl ) ester-5-methyl ester (hydrochloric acid synthesis of benidipine) 2- (3-nitro-benzylidene) acetoacetic acid methyl ester 25g and (0.1 mol) 3-aminocrotonate-3-(N-benzyl) piperidinyl ester 33 g (0.11 mol) and molecular sieves 15g and ethanol The solution of was reacted at 50 ° C. for 10 hours. Next, 150 ml of chloroform and 52 g of 35% hydrochloric acid are added to the residue obtained by distilling off the solvent after removing the molecular sieve, and the mixture is reacted at room temperature for 30 minutes to produce the desired hydrochloride. Next, the solvent is distilled off and the residue obtained is dissolved in ethanol / acetone = 65 ml / 130 ml, and slowly cooled to 5 ° C. or lower with stirring. After about 20 hours, the precipitated crystals were collected by filtration, washed with acetone, and then dried under reduced pressure at room temperature in a desiccator. A yellow crystal having a melting point of 198 ° C., ie, 19 g of benidipine hydrochloride was obtained. Yield 70%. Was analyzed by HPLC, area percentage of the main ingredients are target compound 99.9%, di 3- (N- benzyl) piperidinyl ester was 0.1%.

比較例1
2,6−ジメチル−4−(3−ニトロフェニル)−1,4−ジヒドロピリジン−3,5−ジカルボン酸−3−(1−ベンジル−3−ピペリジニル)エステル−5−メチルエステルの塩酸塩(塩酸ベニジピン)の合成
2−(3−ニトロベンジリデン)アセト酢酸メチルエステル25g(0.1mol)と3−アミノクロトン酸−3−(N−ベンジル)ピペリジニルエステル33g(0.11mol)及びエタノールの溶液を50℃にて10時間反応した。次いで溶媒を留去して得られた残留物にクロロホルム150ml、35%塩酸52gを加え室温で30分反応させ目的の塩酸塩をつくる。次いで溶媒を留去して得られた残留物にエタノール/アセトン=65ml/130mlにて溶解し、攪拌しながらゆっくりと5℃以下まで冷却する。約20時間後、析出した結晶を濾取して、アセトンで洗浄し、次いでデシケーター中室温で減圧乾燥した。
融点198℃の黄色の結晶19gを得た。収率70%。HPLCで分析した結果、主用成分の面積百分率は、目的化合物99.3%、ジ3−(N−ベンジル)ピペリジニルエステル0.7%であった。
Comparative Example 1
Hydrochloride of 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid-3- (1-benzyl-3- piperidinyl ) ester-5-methyl ester (hydrochloric acid synthesis of benidipine) 2- (3-nitro-benzylidene) -3-methyl acetoacetate 25 g (0.1 mol) and 3-aminocrotonate (N- benzyl) piperidinyl ester 33 g (0.11 mol) and a solution of 50 in ethanol The reaction was carried out at 0 ° C. for 10 hours. Next, 150 ml of chloroform and 52 g of 35% hydrochloric acid are added to the residue obtained by distilling off the solvent, and the mixture is reacted at room temperature for 30 minutes to produce the desired hydrochloride. Next, the solvent is distilled off and the residue obtained is dissolved in ethanol / acetone = 65 ml / 130 ml, and slowly cooled to 5 ° C. or lower with stirring. After about 20 hours, the precipitated crystals were collected by filtration, washed with acetone, and then dried under reduced pressure at room temperature in a desiccator.
19 g of yellow crystals having a melting point of 198 ° C. were obtained. Yield 70%. Was analyzed by HPLC, area percentage of the main ingredients are target compound 99.3%, di 3- (N- benzyl) piperidinyl ester was 0.7%.

比較例2
2,6−ジメチル−4−(3−ニトロフェニル)−1,4−ジヒドロピリジン−3,5−ジカルボン酸−3−(1−ベンジル−3−ピペリジニル)エステル−5−メチルエステルの塩酸塩(塩酸ベニジピン)の合成
2−(3−ニトロベンジリデン)アセト酢酸メチルエステル25g(0.1mol)と3−アミノクロトン酸−3−(N−ベンジル)ピペリジニルエステル33g(0.11mol)及びn−ブタノールの溶液を5時間加熱還流した。次いで溶媒を留去して得られた残留物にクロロホルム150ml、35%塩酸52gを加え室温で30分反応させ目的の塩酸塩をつくった。次いで溶媒を留去して得られた残留物にエタノール/アセトン=65ml/130mlにて溶解し、攪拌しながらゆっくりと5℃以下まで冷却した。約20時間後、析出した結晶を濾取して、アセトンで洗浄し、次いでデシケーター中室温で減圧乾燥した。融点198℃の黄色の結晶19gを得た。収率70%。HPLCで分析した結果、主用成分の面積百分率は、目的化合物99.0%、ジ3−(N−ベンジル)ピペリジニルエステル0.7%、ブチル 3−(N−ベンジル)ピペリジニルエステル0.3%であった。
Comparative Example 2
Hydrochloride of 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid-3- (1-benzyl-3- piperidinyl ) ester-5-methyl ester (hydrochloric acid solution of the synthesis 2- (3-nitro-benzylidene) acetoacetic acid methyl ester 25g and (0.1 mol) 3-aminocrotonate-3-(N-benzyl) piperidinyl ester 33 g (0.11 mol) and n- butanol benidipine) Was heated to reflux for 5 hours. Next, 150 ml of chloroform and 52 g of 35% hydrochloric acid were added to the residue obtained by distilling off the solvent, and the mixture was reacted at room temperature for 30 minutes to produce the desired hydrochloride. Next, the solvent was distilled off, and the residue obtained was dissolved in ethanol / acetone = 65 ml / 130 ml, and slowly cooled to 5 ° C. or lower with stirring. After about 20 hours, the precipitated crystals were collected by filtration, washed with acetone, and then dried under reduced pressure at room temperature in a desiccator. 19 g of yellow crystals having a melting point of 198 ° C. were obtained. Yield 70%. Was analyzed by HPLC, area percentage of the main ingredients are target compound 99.0%, di 3- (N- benzyl) piperidinyl ester 0.7%, butyl 3- (N- benzyl) piperidinyl ester 0.3% Met.

Claims (6)

下記一般式(1)
Figure 0004544895
[式中R1は、水素原子、ニトロ基、シアノ基、ハロゲン基、トリフルオロメチル基を表す。式中R2は、C1―C6の直鎖、分岐或いは環状の置換又は無置換アルキル基を表す。式中R3は、アルキル基を表す]で表されるベンジリデンアセト酢酸エステル類と
下記一般式(2)
Figure 0004544895

[式中R4は、アルキル基を表す。式中R5は、N−ベンジル−3−ピペリジニル基を表す。]で表されるアミノクロトン酸エステル類との反応において、エタノール中で反応系内に乾燥剤および/または脱水剤を添加し、副生する水を除去しながら反応を行なうことを特徴とする
下記一般式(3)
Figure 0004544895

[式中R1、R2、R3、R4、R5は前記と同一である]で表されるジヒドロピリジン誘導体の製造法。
The following general formula (1)
Figure 0004544895
[Wherein R 1 represents a hydrogen atom, a nitro group, a cyano group, a halogen group, or a trifluoromethyl group. In the formula, R2 represents a C1-C6 linear, branched or cyclic substituted or unsubstituted alkyl group. In the formula, R3 represents an alkyl group] and benzylideneacetoacetic acid esters represented by the following general formula (2)
Figure 0004544895

[Wherein R 4 represents an alkyl group. In the formula, R5 represents an N-benzyl-3-piperidinyl group . In the reaction with aminocrotonic acid esters represented by the following formula, the reaction is performed while adding a desiccant and / or a dehydrating agent to the reaction system in ethanol and removing by-product water. General formula (3)
Figure 0004544895

[Wherein R1, R2, R3, R4, and R5 are the same as defined above].
反応系内に添加するものが乾燥剤である請求項1記載のジヒドロピリジン誘導体の製造法。 2. The process for producing a dihydropyridine derivative according to claim 1, wherein the addition to the reaction system is a desiccant. 反応系内に添加する乾燥剤がゼオライトである請求項記載のジヒドロピリジン誘導体の製造法。 The method for producing a dihydropyridine derivative according to claim 2 , wherein the desiccant added to the reaction system is zeolite. 反応系内に添加する乾燥剤がモレキュラーシーブである請求項記載のジヒドロピリジン誘導体の製造法。 The method for producing a dihydropyridine derivative according to claim 3 , wherein the desiccant added to the reaction system is a molecular sieve. R1がニトロ基、R2、R3、R4がメチル基である請求項1〜4のいずれか1項記載のジヒドロピリジン誘導体の製造法。 The method for producing a dihydropyridine derivative according to any one of claims 1 to 4, wherein R1 is a nitro group, and R2, R3, and R4 are methyl groups . 反応が室温乃至加温下で行われる請求項1〜5のいずれか1項記載のジヒドロピリジン誘導体の製造法。The method for producing a dihydropyridine derivative according to any one of claims 1 to 5, wherein the reaction is carried out at room temperature to under heating.
JP2004108165A 2004-03-31 2004-03-31 Method for producing dihydropyridine derivatives Expired - Fee Related JP4544895B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004108165A JP4544895B2 (en) 2004-03-31 2004-03-31 Method for producing dihydropyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004108165A JP4544895B2 (en) 2004-03-31 2004-03-31 Method for producing dihydropyridine derivatives

Publications (2)

Publication Number Publication Date
JP2005289894A JP2005289894A (en) 2005-10-20
JP4544895B2 true JP4544895B2 (en) 2010-09-15

Family

ID=35323251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004108165A Expired - Fee Related JP4544895B2 (en) 2004-03-31 2004-03-31 Method for producing dihydropyridine derivatives

Country Status (1)

Country Link
JP (1) JP4544895B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102351784A (en) * 2011-10-20 2012-02-15 华夏药业集团有限公司 Benidipine hydrochloride crystal form and application thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746215A (en) * 2011-04-18 2012-10-24 张兆勇 Method for preparing high-purity benidipine hydrochloride
CN103408483A (en) * 2013-07-17 2013-11-27 张家港威胜生物医药有限公司 Calcium ion channels antagonist manidipine preparation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59137461A (en) * 1983-01-27 1984-08-07 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPH02149563A (en) * 1988-11-30 1990-06-08 Nisshin Flour Milling Co Ltd Production of 1,4-dihydropyridine derivative containing 2-haloethoxycarbonyl group
JPH04208281A (en) * 1990-11-30 1992-07-29 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59137461A (en) * 1983-01-27 1984-08-07 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPH02149563A (en) * 1988-11-30 1990-06-08 Nisshin Flour Milling Co Ltd Production of 1,4-dihydropyridine derivative containing 2-haloethoxycarbonyl group
JPH04208281A (en) * 1990-11-30 1992-07-29 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102351784A (en) * 2011-10-20 2012-02-15 华夏药业集团有限公司 Benidipine hydrochloride crystal form and application thereof

Also Published As

Publication number Publication date
JP2005289894A (en) 2005-10-20

Similar Documents

Publication Publication Date Title
CA1277666C (en) Asymmetrical alkyl diphenylakylaminoalkyl esters of l, 4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylic acid
EP0529702B1 (en) Dihydropyridine derivatives, their preparation and their use
JPH02348B2 (en)
CZ291430B6 (en) Process for preparing dihydropyridine derivatives
EP1831166B1 (en) Optical resolution method of amlodipine
EP1613591B1 (en) Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof
JP4544895B2 (en) Method for producing dihydropyridine derivatives
JP3763538B1 (en) Industrial production method of high-purity benidipine hydrochloride
JPH11116570A (en) Production of dihydropyridine derivative
KR100646670B1 (en) Improved Process for Preparing Lercanidipine hydrochloride
US6492523B2 (en) Method for preparing amlodipine
JPH02149563A (en) Production of 1,4-dihydropyridine derivative containing 2-haloethoxycarbonyl group
US4769465A (en) Process for the preparation of 2-(N-benzyl-N-methylamino)-ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate and its hydrochloride salt
US20110040097A1 (en) Process for preparing lercanidipine hydrochloride
JP5463051B2 (en) Method for producing 1,4-dihydropyridine derivative
KR100374405B1 (en) A new process for amlodipine besylate
JP3202120B2 (en) 1,4-dihydropyridine derivative and method for producing 1,4-dihydropyridinecarboxylic acid derivative using the same
KR20060104761A (en) Process for preparing lercanidipine hydrochloride
KR910001440B1 (en) Process for preparing 2-(n-benzyl-n-methyl omino)-ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate and its hydrochloride salt
JPH0641063A (en) Pyrrolidine derivative
KR100559800B1 (en) A novel manufacturing process for the preparation of 1,1,N-trimethyl-3,3-diphenylpropyl-2-aminomethyl-1,4-dihydro-2,6-dimethyl-4-3-nitrophenyl-pyridine-3,5-dicarboxylate or salt thereof
JP2966004B2 (en) 3-aminocrotonate
JP2006512287A (en) Industrial process for the synthesis of isobutylmethyl 1,4-dihydro-2,6-dimethyl-4- (2-nitrophenyl) -3,5-pyridinedicarboxylate (Nisoldipine)
JPH0544943B2 (en)
JPH08217749A (en) New production of nicardipine hydrochloride and new synthetic intermediate

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061130

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070725

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100406

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100607

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100622

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100629

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130709

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees